Kim D. Blickenstaff is the chairman, chief executive officer and co-founder of Biosite Inc. He has more than 25 years of health care experience in finance, marketing management, sales and strategic planning. Over the past 18 years, he has built Biosite from a startup company of four employees to a public company with more than $280 million in annual revenues and more than 1,000 employees.
Biosite is a medical diagnostics company focused on revolutionizing health care through product innovation. The company is dedicated to the discovery and development of novel protein-based diagnostics that improve a physician's ability to diagnose debilitating and life-threatening diseases.
Biosite also has a charitable giving program, which is dedicated to helping enhance quality of life through volunteers and mentors sharing their expertise, though financial support and by providing novel, rapid diagnostics that improve the diagnosis of critical diseases.